Global Transdermal Patch Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Transdermal Patch market size was valued at US$ 7498 million in 2024 and is forecast to a readjusted size of USD 9524 million by 2031 with a CAGR of 3.5% during review period.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
This report is a detailed and comprehensive analysis for global Transdermal Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transdermal Patch market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
Global Transdermal Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
Global Transdermal Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
Global Transdermal Patch market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (USD/Pc), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transdermal Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transdermal Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal, IBSA Group, GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Transdermal Patch market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transdermal Patch, with price, sales quantity, revenue, and global market share of Transdermal Patch from 2020 to 2025.
Chapter 3, the Transdermal Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Transdermal Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Patch.
Chapter 14 and 15, to describe Transdermal Patch sales channel, distributors, customers, research findings and conclusion.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.
Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.
Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.
This report is a detailed and comprehensive analysis for global Transdermal Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transdermal Patch market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
Global Transdermal Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
Global Transdermal Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (USD/Pc), 2020-2031
Global Transdermal Patch market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (USD/Pc), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transdermal Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transdermal Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal, IBSA Group, GSK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Transdermal Patch market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
- Rx Channel
- OTC Channel
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Novartis
- UCB Pharma
- Mylan
- Teva Pharmaceutical
- Nitto Denko
- Gr?nenthal
- IBSA Group
- GSK
- Luye Pharma Group
- Pfizer
- Chattem
- Dr Reddy’s Laboratories
- Bayer
- Mundipharma
- Endo International
- Beijing Tide Pharmaceutical
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Transdermal Patch, with price, sales quantity, revenue, and global market share of Transdermal Patch from 2020 to 2025.
Chapter 3, the Transdermal Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Transdermal Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Transdermal Patch.
Chapter 14 and 15, to describe Transdermal Patch sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Transdermal Patch Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Methyl Salicylate-based Patch
1.3.3 Rivastigmine Transdermal Patch
1.3.4 Fentanyl Transdermal Patch
1.3.5 Lidocaine Patch
1.3.6 Diclofenac Patch
1.3.7 Nicotine Transdermal Patch
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Transdermal Patch Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Rx Channel
1.4.3 OTC Channel
1.5 Global Transdermal Patch Market Size & Forecast
1.5.1 Global Transdermal Patch Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Transdermal Patch Sales Quantity (2020-2031)
1.5.3 Global Transdermal Patch Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Patch Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Transdermal Patch Product and Services
2.2.4 Johnson & Johnson Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Transdermal Patch Product and Services
2.3.4 Novartis Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Novartis Recent Developments/Updates
2.4 UCB Pharma
2.4.1 UCB Pharma Details
2.4.2 UCB Pharma Major Business
2.4.3 UCB Pharma Transdermal Patch Product and Services
2.4.4 UCB Pharma Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 UCB Pharma Recent Developments/Updates
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Transdermal Patch Product and Services
2.5.4 Mylan Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Mylan Recent Developments/Updates
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Transdermal Patch Product and Services
2.6.4 Teva Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Teva Pharmaceutical Recent Developments/Updates
2.7 Nitto Denko
2.7.1 Nitto Denko Details
2.7.2 Nitto Denko Major Business
2.7.3 Nitto Denko Transdermal Patch Product and Services
2.7.4 Nitto Denko Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Nitto Denko Recent Developments/Updates
2.8 Gr?nenthal
2.8.1 Gr?nenthal Details
2.8.2 Gr?nenthal Major Business
2.8.3 Gr?nenthal Transdermal Patch Product and Services
2.8.4 Gr?nenthal Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Gr?nenthal Recent Developments/Updates
2.9 IBSA Group
2.9.1 IBSA Group Details
2.9.2 IBSA Group Major Business
2.9.3 IBSA Group Transdermal Patch Product and Services
2.9.4 IBSA Group Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 IBSA Group Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Transdermal Patch Product and Services
2.10.4 GSK Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 GSK Recent Developments/Updates
2.11 Luye Pharma Group
2.11.1 Luye Pharma Group Details
2.11.2 Luye Pharma Group Major Business
2.11.3 Luye Pharma Group Transdermal Patch Product and Services
2.11.4 Luye Pharma Group Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Luye Pharma Group Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Transdermal Patch Product and Services
2.12.4 Pfizer Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Pfizer Recent Developments/Updates
2.13 Chattem
2.13.1 Chattem Details
2.13.2 Chattem Major Business
2.13.3 Chattem Transdermal Patch Product and Services
2.13.4 Chattem Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Chattem Recent Developments/Updates
2.14 Dr Reddy’s Laboratories
2.14.1 Dr Reddy’s Laboratories Details
2.14.2 Dr Reddy’s Laboratories Major Business
2.14.3 Dr Reddy’s Laboratories Transdermal Patch Product and Services
2.14.4 Dr Reddy’s Laboratories Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Transdermal Patch Product and Services
2.15.4 Bayer Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Bayer Recent Developments/Updates
2.16 Mundipharma
2.16.1 Mundipharma Details
2.16.2 Mundipharma Major Business
2.16.3 Mundipharma Transdermal Patch Product and Services
2.16.4 Mundipharma Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Mundipharma Recent Developments/Updates
2.17 Endo International
2.17.1 Endo International Details
2.17.2 Endo International Major Business
2.17.3 Endo International Transdermal Patch Product and Services
2.17.4 Endo International Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Endo International Recent Developments/Updates
2.18 Beijing Tide Pharmaceutical
2.18.1 Beijing Tide Pharmaceutical Details
2.18.2 Beijing Tide Pharmaceutical Major Business
2.18.3 Beijing Tide Pharmaceutical Transdermal Patch Product and Services
2.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TRANSDERMAL PATCH BY MANUFACTURER
3.1 Global Transdermal Patch Sales Quantity by Manufacturer (2020-2025)
3.2 Global Transdermal Patch Revenue by Manufacturer (2020-2025)
3.3 Global Transdermal Patch Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Transdermal Patch by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Transdermal Patch Manufacturer Market Share in 2024
3.4.3 Top 6 Transdermal Patch Manufacturer Market Share in 2024
3.5 Transdermal Patch Market: Overall Company Footprint Analysis
3.5.1 Transdermal Patch Market: Region Footprint
3.5.2 Transdermal Patch Market: Company Product Type Footprint
3.5.3 Transdermal Patch Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Transdermal Patch Market Size by Region
4.1.1 Global Transdermal Patch Sales Quantity by Region (2020-2031)
4.1.2 Global Transdermal Patch Consumption Value by Region (2020-2031)
4.1.3 Global Transdermal Patch Average Price by Region (2020-2031)
4.2 North America Transdermal Patch Consumption Value (2020-2031)
4.3 Europe Transdermal Patch Consumption Value (2020-2031)
4.4 Asia-Pacific Transdermal Patch Consumption Value (2020-2031)
4.5 South America Transdermal Patch Consumption Value (2020-2031)
4.6 Middle East & Africa Transdermal Patch Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Transdermal Patch Sales Quantity by Type (2020-2031)
5.2 Global Transdermal Patch Consumption Value by Type (2020-2031)
5.3 Global Transdermal Patch Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Transdermal Patch Sales Quantity by Application (2020-2031)
6.2 Global Transdermal Patch Consumption Value by Application (2020-2031)
6.3 Global Transdermal Patch Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Transdermal Patch Sales Quantity by Type (2020-2031)
7.2 North America Transdermal Patch Sales Quantity by Application (2020-2031)
7.3 North America Transdermal Patch Market Size by Country
7.3.1 North America Transdermal Patch Sales Quantity by Country (2020-2031)
7.3.2 North America Transdermal Patch Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Transdermal Patch Sales Quantity by Type (2020-2031)
8.2 Europe Transdermal Patch Sales Quantity by Application (2020-2031)
8.3 Europe Transdermal Patch Market Size by Country
8.3.1 Europe Transdermal Patch Sales Quantity by Country (2020-2031)
8.3.2 Europe Transdermal Patch Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Transdermal Patch Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Transdermal Patch Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Transdermal Patch Market Size by Region
9.3.1 Asia-Pacific Transdermal Patch Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Transdermal Patch Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Transdermal Patch Sales Quantity by Type (2020-2031)
10.2 South America Transdermal Patch Sales Quantity by Application (2020-2031)
10.3 South America Transdermal Patch Market Size by Country
10.3.1 South America Transdermal Patch Sales Quantity by Country (2020-2031)
10.3.2 South America Transdermal Patch Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Transdermal Patch Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Transdermal Patch Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Transdermal Patch Market Size by Country
11.3.1 Middle East & Africa Transdermal Patch Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Transdermal Patch Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Transdermal Patch Market Drivers
12.2 Transdermal Patch Market Restraints
12.3 Transdermal Patch Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Transdermal Patch and Key Manufacturers
13.2 Manufacturing Costs Percentage of Transdermal Patch
13.3 Transdermal Patch Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Transdermal Patch Typical Distributors
14.3 Transdermal Patch Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Transdermal Patch Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Methyl Salicylate-based Patch
1.3.3 Rivastigmine Transdermal Patch
1.3.4 Fentanyl Transdermal Patch
1.3.5 Lidocaine Patch
1.3.6 Diclofenac Patch
1.3.7 Nicotine Transdermal Patch
1.3.8 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Transdermal Patch Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Rx Channel
1.4.3 OTC Channel
1.5 Global Transdermal Patch Market Size & Forecast
1.5.1 Global Transdermal Patch Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Transdermal Patch Sales Quantity (2020-2031)
1.5.3 Global Transdermal Patch Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Patch Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Hisamitsu Pharmaceutical Recent Developments/Updates
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Transdermal Patch Product and Services
2.2.4 Johnson & Johnson Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Johnson & Johnson Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Transdermal Patch Product and Services
2.3.4 Novartis Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Novartis Recent Developments/Updates
2.4 UCB Pharma
2.4.1 UCB Pharma Details
2.4.2 UCB Pharma Major Business
2.4.3 UCB Pharma Transdermal Patch Product and Services
2.4.4 UCB Pharma Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 UCB Pharma Recent Developments/Updates
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Transdermal Patch Product and Services
2.5.4 Mylan Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Mylan Recent Developments/Updates
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Transdermal Patch Product and Services
2.6.4 Teva Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Teva Pharmaceutical Recent Developments/Updates
2.7 Nitto Denko
2.7.1 Nitto Denko Details
2.7.2 Nitto Denko Major Business
2.7.3 Nitto Denko Transdermal Patch Product and Services
2.7.4 Nitto Denko Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Nitto Denko Recent Developments/Updates
2.8 Gr?nenthal
2.8.1 Gr?nenthal Details
2.8.2 Gr?nenthal Major Business
2.8.3 Gr?nenthal Transdermal Patch Product and Services
2.8.4 Gr?nenthal Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Gr?nenthal Recent Developments/Updates
2.9 IBSA Group
2.9.1 IBSA Group Details
2.9.2 IBSA Group Major Business
2.9.3 IBSA Group Transdermal Patch Product and Services
2.9.4 IBSA Group Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 IBSA Group Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Transdermal Patch Product and Services
2.10.4 GSK Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 GSK Recent Developments/Updates
2.11 Luye Pharma Group
2.11.1 Luye Pharma Group Details
2.11.2 Luye Pharma Group Major Business
2.11.3 Luye Pharma Group Transdermal Patch Product and Services
2.11.4 Luye Pharma Group Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Luye Pharma Group Recent Developments/Updates
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Transdermal Patch Product and Services
2.12.4 Pfizer Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Pfizer Recent Developments/Updates
2.13 Chattem
2.13.1 Chattem Details
2.13.2 Chattem Major Business
2.13.3 Chattem Transdermal Patch Product and Services
2.13.4 Chattem Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Chattem Recent Developments/Updates
2.14 Dr Reddy’s Laboratories
2.14.1 Dr Reddy’s Laboratories Details
2.14.2 Dr Reddy’s Laboratories Major Business
2.14.3 Dr Reddy’s Laboratories Transdermal Patch Product and Services
2.14.4 Dr Reddy’s Laboratories Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Dr Reddy’s Laboratories Recent Developments/Updates
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Transdermal Patch Product and Services
2.15.4 Bayer Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Bayer Recent Developments/Updates
2.16 Mundipharma
2.16.1 Mundipharma Details
2.16.2 Mundipharma Major Business
2.16.3 Mundipharma Transdermal Patch Product and Services
2.16.4 Mundipharma Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Mundipharma Recent Developments/Updates
2.17 Endo International
2.17.1 Endo International Details
2.17.2 Endo International Major Business
2.17.3 Endo International Transdermal Patch Product and Services
2.17.4 Endo International Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Endo International Recent Developments/Updates
2.18 Beijing Tide Pharmaceutical
2.18.1 Beijing Tide Pharmaceutical Details
2.18.2 Beijing Tide Pharmaceutical Major Business
2.18.3 Beijing Tide Pharmaceutical Transdermal Patch Product and Services
2.18.4 Beijing Tide Pharmaceutical Transdermal Patch Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Beijing Tide Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TRANSDERMAL PATCH BY MANUFACTURER
3.1 Global Transdermal Patch Sales Quantity by Manufacturer (2020-2025)
3.2 Global Transdermal Patch Revenue by Manufacturer (2020-2025)
3.3 Global Transdermal Patch Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Transdermal Patch by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Transdermal Patch Manufacturer Market Share in 2024
3.4.3 Top 6 Transdermal Patch Manufacturer Market Share in 2024
3.5 Transdermal Patch Market: Overall Company Footprint Analysis
3.5.1 Transdermal Patch Market: Region Footprint
3.5.2 Transdermal Patch Market: Company Product Type Footprint
3.5.3 Transdermal Patch Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Transdermal Patch Market Size by Region
4.1.1 Global Transdermal Patch Sales Quantity by Region (2020-2031)
4.1.2 Global Transdermal Patch Consumption Value by Region (2020-2031)
4.1.3 Global Transdermal Patch Average Price by Region (2020-2031)
4.2 North America Transdermal Patch Consumption Value (2020-2031)
4.3 Europe Transdermal Patch Consumption Value (2020-2031)
4.4 Asia-Pacific Transdermal Patch Consumption Value (2020-2031)
4.5 South America Transdermal Patch Consumption Value (2020-2031)
4.6 Middle East & Africa Transdermal Patch Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Transdermal Patch Sales Quantity by Type (2020-2031)
5.2 Global Transdermal Patch Consumption Value by Type (2020-2031)
5.3 Global Transdermal Patch Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Transdermal Patch Sales Quantity by Application (2020-2031)
6.2 Global Transdermal Patch Consumption Value by Application (2020-2031)
6.3 Global Transdermal Patch Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Transdermal Patch Sales Quantity by Type (2020-2031)
7.2 North America Transdermal Patch Sales Quantity by Application (2020-2031)
7.3 North America Transdermal Patch Market Size by Country
7.3.1 North America Transdermal Patch Sales Quantity by Country (2020-2031)
7.3.2 North America Transdermal Patch Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Transdermal Patch Sales Quantity by Type (2020-2031)
8.2 Europe Transdermal Patch Sales Quantity by Application (2020-2031)
8.3 Europe Transdermal Patch Market Size by Country
8.3.1 Europe Transdermal Patch Sales Quantity by Country (2020-2031)
8.3.2 Europe Transdermal Patch Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Transdermal Patch Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Transdermal Patch Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Transdermal Patch Market Size by Region
9.3.1 Asia-Pacific Transdermal Patch Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Transdermal Patch Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Transdermal Patch Sales Quantity by Type (2020-2031)
10.2 South America Transdermal Patch Sales Quantity by Application (2020-2031)
10.3 South America Transdermal Patch Market Size by Country
10.3.1 South America Transdermal Patch Sales Quantity by Country (2020-2031)
10.3.2 South America Transdermal Patch Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Transdermal Patch Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Transdermal Patch Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Transdermal Patch Market Size by Country
11.3.1 Middle East & Africa Transdermal Patch Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Transdermal Patch Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Transdermal Patch Market Drivers
12.2 Transdermal Patch Market Restraints
12.3 Transdermal Patch Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Transdermal Patch and Key Manufacturers
13.2 Manufacturing Costs Percentage of Transdermal Patch
13.3 Transdermal Patch Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Transdermal Patch Typical Distributors
14.3 Transdermal Patch Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Transdermal Patch Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Transdermal Patch Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Pharmaceutical Major Business
Table 5. Hisamitsu Pharmaceutical Transdermal Patch Product and Services
Table 6. Hisamitsu Pharmaceutical Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Transdermal Patch Product and Services
Table 11. Johnson & Johnson Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Transdermal Patch Product and Services
Table 16. Novartis Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Novartis Recent Developments/Updates
Table 18. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 19. UCB Pharma Major Business
Table 20. UCB Pharma Transdermal Patch Product and Services
Table 21. UCB Pharma Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. UCB Pharma Recent Developments/Updates
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Transdermal Patch Product and Services
Table 26. Mylan Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Mylan Recent Developments/Updates
Table 28. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Major Business
Table 30. Teva Pharmaceutical Transdermal Patch Product and Services
Table 31. Teva Pharmaceutical Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Teva Pharmaceutical Recent Developments/Updates
Table 33. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 34. Nitto Denko Major Business
Table 35. Nitto Denko Transdermal Patch Product and Services
Table 36. Nitto Denko Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Nitto Denko Recent Developments/Updates
Table 38. Gr?nenthal Basic Information, Manufacturing Base and Competitors
Table 39. Gr?nenthal Major Business
Table 40. Gr?nenthal Transdermal Patch Product and Services
Table 41. Gr?nenthal Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Gr?nenthal Recent Developments/Updates
Table 43. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 44. IBSA Group Major Business
Table 45. IBSA Group Transdermal Patch Product and Services
Table 46. IBSA Group Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. IBSA Group Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Transdermal Patch Product and Services
Table 51. GSK Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. GSK Recent Developments/Updates
Table 53. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 54. Luye Pharma Group Major Business
Table 55. Luye Pharma Group Transdermal Patch Product and Services
Table 56. Luye Pharma Group Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Luye Pharma Group Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Transdermal Patch Product and Services
Table 61. Pfizer Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Pfizer Recent Developments/Updates
Table 63. Chattem Basic Information, Manufacturing Base and Competitors
Table 64. Chattem Major Business
Table 65. Chattem Transdermal Patch Product and Services
Table 66. Chattem Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Chattem Recent Developments/Updates
Table 68. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 69. Dr Reddy’s Laboratories Major Business
Table 70. Dr Reddy’s Laboratories Transdermal Patch Product and Services
Table 71. Dr Reddy’s Laboratories Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Dr Reddy’s Laboratories Recent Developments/Updates
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Transdermal Patch Product and Services
Table 76. Bayer Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Bayer Recent Developments/Updates
Table 78. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 79. Mundipharma Major Business
Table 80. Mundipharma Transdermal Patch Product and Services
Table 81. Mundipharma Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Mundipharma Recent Developments/Updates
Table 83. Endo International Basic Information, Manufacturing Base and Competitors
Table 84. Endo International Major Business
Table 85. Endo International Transdermal Patch Product and Services
Table 86. Endo International Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Endo International Recent Developments/Updates
Table 88. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Beijing Tide Pharmaceutical Major Business
Table 90. Beijing Tide Pharmaceutical Transdermal Patch Product and Services
Table 91. Beijing Tide Pharmaceutical Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 93. Global Transdermal Patch Sales Quantity by Manufacturer (2020-2025) & (M Pcs)
Table 94. Global Transdermal Patch Revenue by Manufacturer (2020-2025) & (USD Million)
Table 95. Global Transdermal Patch Average Price by Manufacturer (2020-2025) & (USD/Pc)
Table 96. Market Position of Manufacturers in Transdermal Patch, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 97. Head Office and Transdermal Patch Production Site of Key Manufacturer
Table 98. Transdermal Patch Market: Company Product Type Footprint
Table 99. Transdermal Patch Market: Company Product Application Footprint
Table 100. Transdermal Patch New Market Entrants and Barriers to Market Entry
Table 101. Transdermal Patch Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Transdermal Patch Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 103. Global Transdermal Patch Sales Quantity by Region (2020-2025) & (M Pcs)
Table 104. Global Transdermal Patch Sales Quantity by Region (2026-2031) & (M Pcs)
Table 105. Global Transdermal Patch Consumption Value by Region (2020-2025) & (USD Million)
Table 106. Global Transdermal Patch Consumption Value by Region (2026-2031) & (USD Million)
Table 107. Global Transdermal Patch Average Price by Region (2020-2025) & (USD/Pc)
Table 108. Global Transdermal Patch Average Price by Region (2026-2031) & (USD/Pc)
Table 109. Global Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 110. Global Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 111. Global Transdermal Patch Consumption Value by Type (2020-2025) & (USD Million)
Table 112. Global Transdermal Patch Consumption Value by Type (2026-2031) & (USD Million)
Table 113. Global Transdermal Patch Average Price by Type (2020-2025) & (USD/Pc)
Table 114. Global Transdermal Patch Average Price by Type (2026-2031) & (USD/Pc)
Table 115. Global Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 116. Global Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 117. Global Transdermal Patch Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Global Transdermal Patch Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Global Transdermal Patch Average Price by Application (2020-2025) & (USD/Pc)
Table 120. Global Transdermal Patch Average Price by Application (2026-2031) & (USD/Pc)
Table 121. North America Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 122. North America Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 123. North America Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 124. North America Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 125. North America Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 126. North America Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 127. North America Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 128. North America Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 129. Europe Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 130. Europe Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 131. Europe Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 132. Europe Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 133. Europe Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 134. Europe Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 135. Europe Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 136. Europe Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 137. Asia-Pacific Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 138. Asia-Pacific Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 139. Asia-Pacific Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 140. Asia-Pacific Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 141. Asia-Pacific Transdermal Patch Sales Quantity by Region (2020-2025) & (M Pcs)
Table 142. Asia-Pacific Transdermal Patch Sales Quantity by Region (2026-2031) & (M Pcs)
Table 143. Asia-Pacific Transdermal Patch Consumption Value by Region (2020-2025) & (USD Million)
Table 144. Asia-Pacific Transdermal Patch Consumption Value by Region (2026-2031) & (USD Million)
Table 145. South America Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 146. South America Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 147. South America Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 148. South America Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 149. South America Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 150. South America Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 151. South America Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 152. South America Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 153. Middle East & Africa Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 154. Middle East & Africa Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 155. Middle East & Africa Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 156. Middle East & Africa Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 157. Middle East & Africa Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 158. Middle East & Africa Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 159. Middle East & Africa Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 160. Middle East & Africa Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 161. Transdermal Patch Raw Material
Table 162. Key Manufacturers of Transdermal Patch Raw Materials
Table 163. Transdermal Patch Typical Distributors
Table 164. Transdermal Patch Typical Customers
Table 1. Global Transdermal Patch Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Transdermal Patch Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Pharmaceutical Major Business
Table 5. Hisamitsu Pharmaceutical Transdermal Patch Product and Services
Table 6. Hisamitsu Pharmaceutical Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson & Johnson Major Business
Table 10. Johnson & Johnson Transdermal Patch Product and Services
Table 11. Johnson & Johnson Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Johnson & Johnson Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Transdermal Patch Product and Services
Table 16. Novartis Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Novartis Recent Developments/Updates
Table 18. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 19. UCB Pharma Major Business
Table 20. UCB Pharma Transdermal Patch Product and Services
Table 21. UCB Pharma Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. UCB Pharma Recent Developments/Updates
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Transdermal Patch Product and Services
Table 26. Mylan Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Mylan Recent Developments/Updates
Table 28. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Teva Pharmaceutical Major Business
Table 30. Teva Pharmaceutical Transdermal Patch Product and Services
Table 31. Teva Pharmaceutical Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Teva Pharmaceutical Recent Developments/Updates
Table 33. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 34. Nitto Denko Major Business
Table 35. Nitto Denko Transdermal Patch Product and Services
Table 36. Nitto Denko Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Nitto Denko Recent Developments/Updates
Table 38. Gr?nenthal Basic Information, Manufacturing Base and Competitors
Table 39. Gr?nenthal Major Business
Table 40. Gr?nenthal Transdermal Patch Product and Services
Table 41. Gr?nenthal Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Gr?nenthal Recent Developments/Updates
Table 43. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 44. IBSA Group Major Business
Table 45. IBSA Group Transdermal Patch Product and Services
Table 46. IBSA Group Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. IBSA Group Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Transdermal Patch Product and Services
Table 51. GSK Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. GSK Recent Developments/Updates
Table 53. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 54. Luye Pharma Group Major Business
Table 55. Luye Pharma Group Transdermal Patch Product and Services
Table 56. Luye Pharma Group Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Luye Pharma Group Recent Developments/Updates
Table 58. Pfizer Basic Information, Manufacturing Base and Competitors
Table 59. Pfizer Major Business
Table 60. Pfizer Transdermal Patch Product and Services
Table 61. Pfizer Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Pfizer Recent Developments/Updates
Table 63. Chattem Basic Information, Manufacturing Base and Competitors
Table 64. Chattem Major Business
Table 65. Chattem Transdermal Patch Product and Services
Table 66. Chattem Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Chattem Recent Developments/Updates
Table 68. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 69. Dr Reddy’s Laboratories Major Business
Table 70. Dr Reddy’s Laboratories Transdermal Patch Product and Services
Table 71. Dr Reddy’s Laboratories Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Dr Reddy’s Laboratories Recent Developments/Updates
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Transdermal Patch Product and Services
Table 76. Bayer Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Bayer Recent Developments/Updates
Table 78. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 79. Mundipharma Major Business
Table 80. Mundipharma Transdermal Patch Product and Services
Table 81. Mundipharma Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Mundipharma Recent Developments/Updates
Table 83. Endo International Basic Information, Manufacturing Base and Competitors
Table 84. Endo International Major Business
Table 85. Endo International Transdermal Patch Product and Services
Table 86. Endo International Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Endo International Recent Developments/Updates
Table 88. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Beijing Tide Pharmaceutical Major Business
Table 90. Beijing Tide Pharmaceutical Transdermal Patch Product and Services
Table 91. Beijing Tide Pharmaceutical Transdermal Patch Sales Quantity (M Pcs), Average Price (USD/Pc), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 93. Global Transdermal Patch Sales Quantity by Manufacturer (2020-2025) & (M Pcs)
Table 94. Global Transdermal Patch Revenue by Manufacturer (2020-2025) & (USD Million)
Table 95. Global Transdermal Patch Average Price by Manufacturer (2020-2025) & (USD/Pc)
Table 96. Market Position of Manufacturers in Transdermal Patch, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 97. Head Office and Transdermal Patch Production Site of Key Manufacturer
Table 98. Transdermal Patch Market: Company Product Type Footprint
Table 99. Transdermal Patch Market: Company Product Application Footprint
Table 100. Transdermal Patch New Market Entrants and Barriers to Market Entry
Table 101. Transdermal Patch Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Transdermal Patch Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 103. Global Transdermal Patch Sales Quantity by Region (2020-2025) & (M Pcs)
Table 104. Global Transdermal Patch Sales Quantity by Region (2026-2031) & (M Pcs)
Table 105. Global Transdermal Patch Consumption Value by Region (2020-2025) & (USD Million)
Table 106. Global Transdermal Patch Consumption Value by Region (2026-2031) & (USD Million)
Table 107. Global Transdermal Patch Average Price by Region (2020-2025) & (USD/Pc)
Table 108. Global Transdermal Patch Average Price by Region (2026-2031) & (USD/Pc)
Table 109. Global Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 110. Global Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 111. Global Transdermal Patch Consumption Value by Type (2020-2025) & (USD Million)
Table 112. Global Transdermal Patch Consumption Value by Type (2026-2031) & (USD Million)
Table 113. Global Transdermal Patch Average Price by Type (2020-2025) & (USD/Pc)
Table 114. Global Transdermal Patch Average Price by Type (2026-2031) & (USD/Pc)
Table 115. Global Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 116. Global Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 117. Global Transdermal Patch Consumption Value by Application (2020-2025) & (USD Million)
Table 118. Global Transdermal Patch Consumption Value by Application (2026-2031) & (USD Million)
Table 119. Global Transdermal Patch Average Price by Application (2020-2025) & (USD/Pc)
Table 120. Global Transdermal Patch Average Price by Application (2026-2031) & (USD/Pc)
Table 121. North America Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 122. North America Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 123. North America Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 124. North America Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 125. North America Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 126. North America Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 127. North America Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 128. North America Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 129. Europe Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 130. Europe Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 131. Europe Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 132. Europe Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 133. Europe Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 134. Europe Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 135. Europe Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 136. Europe Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 137. Asia-Pacific Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 138. Asia-Pacific Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 139. Asia-Pacific Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 140. Asia-Pacific Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 141. Asia-Pacific Transdermal Patch Sales Quantity by Region (2020-2025) & (M Pcs)
Table 142. Asia-Pacific Transdermal Patch Sales Quantity by Region (2026-2031) & (M Pcs)
Table 143. Asia-Pacific Transdermal Patch Consumption Value by Region (2020-2025) & (USD Million)
Table 144. Asia-Pacific Transdermal Patch Consumption Value by Region (2026-2031) & (USD Million)
Table 145. South America Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 146. South America Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 147. South America Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 148. South America Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 149. South America Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 150. South America Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 151. South America Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 152. South America Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 153. Middle East & Africa Transdermal Patch Sales Quantity by Type (2020-2025) & (M Pcs)
Table 154. Middle East & Africa Transdermal Patch Sales Quantity by Type (2026-2031) & (M Pcs)
Table 155. Middle East & Africa Transdermal Patch Sales Quantity by Application (2020-2025) & (M Pcs)
Table 156. Middle East & Africa Transdermal Patch Sales Quantity by Application (2026-2031) & (M Pcs)
Table 157. Middle East & Africa Transdermal Patch Sales Quantity by Country (2020-2025) & (M Pcs)
Table 158. Middle East & Africa Transdermal Patch Sales Quantity by Country (2026-2031) & (M Pcs)
Table 159. Middle East & Africa Transdermal Patch Consumption Value by Country (2020-2025) & (USD Million)
Table 160. Middle East & Africa Transdermal Patch Consumption Value by Country (2026-2031) & (USD Million)
Table 161. Transdermal Patch Raw Material
Table 162. Key Manufacturers of Transdermal Patch Raw Materials
Table 163. Transdermal Patch Typical Distributors
Table 164. Transdermal Patch Typical Customers
LIST OF FIGURES
Figure 1. Transdermal Patch Picture
Figure 2. Global Transdermal Patch Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Transdermal Patch Revenue Market Share by Type in 2024
Figure 4. Methyl Salicylate-based Patch Examples
Figure 5. Rivastigmine Transdermal Patch Examples
Figure 6. Fentanyl Transdermal Patch Examples
Figure 7. Lidocaine Patch Examples
Figure 8. Diclofenac Patch Examples
Figure 9. Nicotine Transdermal Patch Examples
Figure 10. Others Examples
Figure 11. Global Transdermal Patch Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 12. Global Transdermal Patch Revenue Market Share by Application in 2024
Figure 13. Rx Channel Examples
Figure 14. OTC Channel Examples
Figure 15. Global Transdermal Patch Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Transdermal Patch Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Transdermal Patch Sales Quantity (2020-2031) & (M Pcs)
Figure 18. Global Transdermal Patch Price (2020-2031) & (USD/Pc)
Figure 19. Global Transdermal Patch Sales Quantity Market Share by Manufacturer in 2024
Figure 20. Global Transdermal Patch Revenue Market Share by Manufacturer in 2024
Figure 21. Producer Shipments of Transdermal Patch by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 22. Top 3 Transdermal Patch Manufacturer (Revenue) Market Share in 2024
Figure 23. Top 6 Transdermal Patch Manufacturer (Revenue) Market Share in 2024
Figure 24. Global Transdermal Patch Sales Quantity Market Share by Region (2020-2031)
Figure 25. Global Transdermal Patch Consumption Value Market Share by Region (2020-2031)
Figure 26. North America Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 27. Europe Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 28. Asia-Pacific Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 29. South America Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 30. Middle East & Africa Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 31. Global Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 32. Global Transdermal Patch Consumption Value Market Share by Type (2020-2031)
Figure 33. Global Transdermal Patch Average Price by Type (2020-2031) & (USD/Pc)
Figure 34. Global Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 35. Global Transdermal Patch Revenue Market Share by Application (2020-2031)
Figure 36. Global Transdermal Patch Average Price by Application (2020-2031) & (USD/Pc)
Figure 37. North America Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 38. North America Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 39. North America Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 40. North America Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 41. United States Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 42. Canada Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 43. Mexico Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 44. Europe Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 45. Europe Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 46. Europe Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 47. Europe Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 48. Germany Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 49. France Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 50. United Kingdom Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 51. Russia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 52. Italy Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 53. Asia-Pacific Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 54. Asia-Pacific Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 55. Asia-Pacific Transdermal Patch Sales Quantity Market Share by Region (2020-2031)
Figure 56. Asia-Pacific Transdermal Patch Consumption Value Market Share by Region (2020-2031)
Figure 57. China Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 58. Japan Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 59. South Korea Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 60. India Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 61. Southeast Asia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 62. Australia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 63. South America Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 64. South America Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 65. South America Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 66. South America Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 67. Brazil Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 68. Argentina Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 69. Middle East & Africa Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 70. Middle East & Africa Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 71. Middle East & Africa Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 72. Middle East & Africa Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 73. Turkey Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 74. Egypt Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 75. Saudi Arabia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 76. South Africa Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 77. Transdermal Patch Market Drivers
Figure 78. Transdermal Patch Market Restraints
Figure 79. Transdermal Patch Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Transdermal Patch in 2024
Figure 82. Manufacturing Process Analysis of Transdermal Patch
Figure 83. Transdermal Patch Industrial Chain
Figure 84. Sales Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. Transdermal Patch Picture
Figure 2. Global Transdermal Patch Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Transdermal Patch Revenue Market Share by Type in 2024
Figure 4. Methyl Salicylate-based Patch Examples
Figure 5. Rivastigmine Transdermal Patch Examples
Figure 6. Fentanyl Transdermal Patch Examples
Figure 7. Lidocaine Patch Examples
Figure 8. Diclofenac Patch Examples
Figure 9. Nicotine Transdermal Patch Examples
Figure 10. Others Examples
Figure 11. Global Transdermal Patch Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 12. Global Transdermal Patch Revenue Market Share by Application in 2024
Figure 13. Rx Channel Examples
Figure 14. OTC Channel Examples
Figure 15. Global Transdermal Patch Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Transdermal Patch Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Transdermal Patch Sales Quantity (2020-2031) & (M Pcs)
Figure 18. Global Transdermal Patch Price (2020-2031) & (USD/Pc)
Figure 19. Global Transdermal Patch Sales Quantity Market Share by Manufacturer in 2024
Figure 20. Global Transdermal Patch Revenue Market Share by Manufacturer in 2024
Figure 21. Producer Shipments of Transdermal Patch by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 22. Top 3 Transdermal Patch Manufacturer (Revenue) Market Share in 2024
Figure 23. Top 6 Transdermal Patch Manufacturer (Revenue) Market Share in 2024
Figure 24. Global Transdermal Patch Sales Quantity Market Share by Region (2020-2031)
Figure 25. Global Transdermal Patch Consumption Value Market Share by Region (2020-2031)
Figure 26. North America Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 27. Europe Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 28. Asia-Pacific Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 29. South America Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 30. Middle East & Africa Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 31. Global Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 32. Global Transdermal Patch Consumption Value Market Share by Type (2020-2031)
Figure 33. Global Transdermal Patch Average Price by Type (2020-2031) & (USD/Pc)
Figure 34. Global Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 35. Global Transdermal Patch Revenue Market Share by Application (2020-2031)
Figure 36. Global Transdermal Patch Average Price by Application (2020-2031) & (USD/Pc)
Figure 37. North America Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 38. North America Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 39. North America Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 40. North America Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 41. United States Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 42. Canada Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 43. Mexico Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 44. Europe Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 45. Europe Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 46. Europe Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 47. Europe Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 48. Germany Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 49. France Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 50. United Kingdom Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 51. Russia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 52. Italy Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 53. Asia-Pacific Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 54. Asia-Pacific Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 55. Asia-Pacific Transdermal Patch Sales Quantity Market Share by Region (2020-2031)
Figure 56. Asia-Pacific Transdermal Patch Consumption Value Market Share by Region (2020-2031)
Figure 57. China Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 58. Japan Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 59. South Korea Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 60. India Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 61. Southeast Asia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 62. Australia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 63. South America Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 64. South America Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 65. South America Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 66. South America Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 67. Brazil Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 68. Argentina Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 69. Middle East & Africa Transdermal Patch Sales Quantity Market Share by Type (2020-2031)
Figure 70. Middle East & Africa Transdermal Patch Sales Quantity Market Share by Application (2020-2031)
Figure 71. Middle East & Africa Transdermal Patch Sales Quantity Market Share by Country (2020-2031)
Figure 72. Middle East & Africa Transdermal Patch Consumption Value Market Share by Country (2020-2031)
Figure 73. Turkey Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 74. Egypt Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 75. Saudi Arabia Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 76. South Africa Transdermal Patch Consumption Value (2020-2031) & (USD Million)
Figure 77. Transdermal Patch Market Drivers
Figure 78. Transdermal Patch Market Restraints
Figure 79. Transdermal Patch Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Transdermal Patch in 2024
Figure 82. Manufacturing Process Analysis of Transdermal Patch
Figure 83. Transdermal Patch Industrial Chain
Figure 84. Sales Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
